30 patients with insomnia were treated in a double-blind 'crossover' study either with estazolam or placebo at the daily dose of 2.4 mg for 30 days. At the end of treatment, improvements were observed. The superiority of therapeutic effect, in relation to placebo, demonstrated that estazolam is an effective drug in the treatment of sleeping disturbances. No side effects were observed.
Valutazioni clinico-sperimentali sull'impiego dell'Estazolam nella terapia dei disturbi del sonno [Experimental-clinical evaluation on estazolam in sleeping disturbances]
RAMPELLO, Liborio;Pennisi G.
1981-01-01
Abstract
30 patients with insomnia were treated in a double-blind 'crossover' study either with estazolam or placebo at the daily dose of 2.4 mg for 30 days. At the end of treatment, improvements were observed. The superiority of therapeutic effect, in relation to placebo, demonstrated that estazolam is an effective drug in the treatment of sleeping disturbances. No side effects were observed.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
Acta Geront. 1981.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
252.17 kB
Formato
Adobe PDF
|
252.17 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.